A Registry Study of Biomarkers in Heart Valve Disease
Recruiting
- Conditions
- Cardiovascular Diseases
- Registration Number
- NCT06223906
- Lead Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases
- Brief Summary
Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200000
Inclusion Criteria
- Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital
Exclusion Criteria
- Age < 18 years
- Failure to obtain medical records and ultrasound data
- Refuse follow-up
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause death These data is collected during follow-up visit at 12 months after discharge whether recidivation happened,whether other related disease happened
- Secondary Outcome Measures
Name Time Method HF rehospitalization These data is collected during follow-up visit at 12 months after discharge heart failure related hospitalization within 1 years of discharge
Trial Locations
- Locations (1)
Beijing Anzhen Hospital
🇨🇳Beijing, Beijing, China